David Nierengarten
Stock Analyst at Wedbush
(4.74)
# 687
Out of 5,060 analysts
584
Total ratings
43.8%
Success rate
15.1%
Average return
Main Sectors:
Stocks Rated by David Nierengarten
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STRO Sutro Biopharma | Maintained: Buy | $60 | $11.18 | +436.67% | 17 | Oct 16, 2026 | |
| ARGX argenx SE | Reiterated: Buy | $1,150 → $1,130 | $854.14 | +32.30% | 62 | Oct 13, 2026 | |
| AKTS Aktis Oncology | Reiterated: Buy | $35 | $16.35 | +114.07% | 2 | Oct 2, 2026 | |
| STTK Shattuck Labs | Reiterated: Buy | $11 → $14 | $5.48 | +155.47% | 5 | Oct 2, 2026 | |
| JBIO Jade Biosciences | Reiterated: Buy | $47 | $13.78 | +241.20% | 1 | Oct 1, 2026 | |
| DMRA Damora Therapeutics | Reiterated: Buy | $40 | $18.41 | +117.27% | 7 | Sep 29, 2026 | |
| CATX Perspective Therapeutics | Reiterated: Buy | $11 | $2.31 | +376.19% | 17 | Sep 25, 2026 | |
| SRRK Scholar Rock Holding | Reiterated: Buy | $70 | $40.41 | +73.22% | 21 | Sep 25, 2026 | |
| XNCR Xencor | Reiterated: Buy | $30 | $23.81 | +26.00% | 18 | Sep 25, 2026 | |
| ABVX ABIVAX Société Anonyme | Reiterated: Hold | $140 → $118 | $88.31 | +33.62% | 7 | Sep 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 | $28.81 | +90.91% | 23 | Sep 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $4.78 | +130.13% | 29 | Sep 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 | $23.67 | +174.61% | 20 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $17 → $13 | $11.31 | +14.94% | 16 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $123 | $79.13 | +55.44% | 13 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $5 → $1 | $0.2131 | +369.26% | 7 | Sep 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $25.21 | +78.50% | 4 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 → $64 | $31.14 | +105.52% | 4 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $88 | $56.24 | +56.49% | 22 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $16.43 | +82.59% | 3 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $72 → $99 | $81.63 | +21.28% | 23 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $18 → $20 | $14.02 | +42.65% | 17 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $165 | $77.28 | +113.51% | 8 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $2.98 | +738.93% | 8 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 | $47.84 | +56.77% | 33 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 | $38.23 | -16.30% | 2 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $6.03 | +281.74% | 5 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $11.81 | +69.35% | 22 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | kr 69.00 | kr 35.74 | +93.06% | 1 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $75 → $35 | $15.25 | n/a | 13 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 | $19.28 | n/a | 11 | Jun 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 → $30 | $17.63 | n/a | 2 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 | $1.97 | n/a | 20 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 | $17.38 | n/a | 10 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 | $4.26 | n/a | 5 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $12 | $3.15 | n/a | 1 | Apr 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9 → $4 | $0.32 | n/a | 23 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4 → $2 | $21.07 | n/a | 5 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $48 → $16 | $75.35 | n/a | 8 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 → $17 | $9.97 | n/a | 6 | Jan 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 → $32 | $3.38 | n/a | 11 | Jun 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9 → $10 | $0.0004 | n/a | 3 | Aug 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 → $36 | $2.04 | n/a | 7 | Jun 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $95 | $662.15 | n/a | 1 | Aug 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $55 → $13 | $8.56 | n/a | 2 | Apr 23, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $19 | $9.79 | n/a | 1 | Dec 21, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $1.08 | n/a | 1 | Nov 28, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 → $16 | $3.25 | n/a | 6 | Oct 12, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 → $13 | $3.73 | n/a | 6 | Oct 24, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.5 → $1 | $0.000001 | n/a | 7 | Aug 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 | $1.15 | n/a | 7 | Aug 3, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 → $3 | $28.16 | n/a | 3 | May 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $9 | $0.7249 | n/a | 4 | Nov 17, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $98.97 | n/a | 3 | Mar 31, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $25.46 | n/a | 1 | Mar 22, 2013 |
Sutro Biopharma
Oct 16, 2026
Maintained: Buy
Price Target: $60
Current: $11.18
Upside: +436.67%
argenx SE
Oct 13, 2026
Reiterated: Buy
Price Target: $1,150 → $1,130
Current: $854.14
Upside: +32.30%
Aktis Oncology
Oct 2, 2026
Reiterated: Buy
Price Target: $35
Current: $16.35
Upside: +114.07%
Shattuck Labs
Oct 2, 2026
Reiterated: Buy
Price Target: $11 → $14
Current: $5.48
Upside: +155.47%
Jade Biosciences
Oct 1, 2026
Reiterated: Buy
Price Target: $47
Current: $13.78
Upside: +241.20%
Damora Therapeutics
Sep 29, 2026
Reiterated: Buy
Price Target: $40
Current: $18.41
Upside: +117.27%
Perspective Therapeutics
Sep 25, 2026
Reiterated: Buy
Price Target: $11
Current: $2.31
Upside: +376.19%
Scholar Rock Holding
Sep 25, 2026
Reiterated: Buy
Price Target: $70
Current: $40.41
Upside: +73.22%
Xencor
Sep 25, 2026
Reiterated: Buy
Price Target: $30
Current: $23.81
Upside: +26.00%
ABIVAX Société Anonyme
Sep 22, 2026
Reiterated: Hold
Price Target: $140 → $118
Current: $88.31
Upside: +33.62%
Sep 16, 2026
Reiterated: Buy
Price Target: $55
Current: $28.81
Upside: +90.91%
Sep 15, 2026
Reiterated: Buy
Price Target: $11
Current: $4.78
Upside: +130.13%
Sep 9, 2026
Reiterated: Buy
Price Target: $65
Current: $23.67
Upside: +174.61%
Sep 9, 2026
Reiterated: Hold
Price Target: $17 → $13
Current: $11.31
Upside: +14.94%
Sep 9, 2026
Reiterated: Buy
Price Target: $123
Current: $79.13
Upside: +55.44%
Sep 3, 2026
Downgraded: Hold
Price Target: $5 → $1
Current: $0.2131
Upside: +369.26%
Aug 14, 2026
Reiterated: Buy
Price Target: $45
Current: $25.21
Upside: +78.50%
Aug 12, 2026
Reiterated: Buy
Price Target: $55 → $64
Current: $31.14
Upside: +105.52%
Aug 11, 2026
Reiterated: Buy
Price Target: $88
Current: $56.24
Upside: +56.49%
Aug 5, 2026
Reiterated: Buy
Price Target: $30
Current: $16.43
Upside: +82.59%
Jul 28, 2026
Reiterated: Buy
Price Target: $72 → $99
Current: $81.63
Upside: +21.28%
Jul 24, 2026
Reiterated: Hold
Price Target: $18 → $20
Current: $14.02
Upside: +42.65%
May 14, 2026
Reiterated: Buy
Price Target: $165
Current: $77.28
Upside: +113.51%
May 13, 2026
Reiterated: Buy
Price Target: $25
Current: $2.98
Upside: +738.93%
Mar 31, 2026
Reiterated: Buy
Price Target: $75
Current: $47.84
Upside: +56.77%
Mar 17, 2026
Reiterated: Buy
Price Target: $32
Current: $38.23
Upside: -16.30%
Mar 11, 2026
Reiterated: Buy
Price Target: $23
Current: $6.03
Upside: +281.74%
Feb 24, 2026
Reiterated: Buy
Price Target: $20
Current: $11.81
Upside: +69.35%
Jan 7, 2026
Initiated Coverage: Buy
Price Target: kr 69.00
Current: kr 35.74
Upside: +93.06%
Oct 14, 2025
Reiterated: Hold
Price Target: $75 → $35
Current: $15.25
Upside: n/a
Jun 26, 2025
Reiterated: Hold
Price Target: $8
Current: $19.28
Upside: n/a
May 23, 2025
Reiterated: Buy
Price Target: $31 → $30
Current: $17.63
Upside: n/a
May 14, 2025
Reiterated: Hold
Price Target: $5
Current: $1.97
Upside: n/a
Mar 20, 2025
Reiterated: Buy
Price Target: $33
Current: $17.38
Upside: n/a
Aug 9, 2024
Reiterated: Hold
Price Target: $2
Current: $4.26
Upside: n/a
Apr 2, 2024
Initiated Coverage: Buy
Price Target: $12
Current: $3.15
Upside: n/a
Jul 26, 2023
Reiterated: Hold
Price Target: $9 → $4
Current: $0.32
Upside: n/a
Jul 12, 2023
Downgraded: Hold
Price Target: $4 → $2
Current: $21.07
Upside: n/a
Jan 26, 2023
Downgraded: Hold
Price Target: $48 → $16
Current: $75.35
Upside: n/a
Jan 25, 2023
Reiterated: Buy
Price Target: $19 → $17
Current: $9.97
Upside: n/a
Jun 16, 2021
Reiterated: Buy
Price Target: $34 → $32
Current: $3.38
Upside: n/a
Aug 7, 2020
Reiterated: Hold
Price Target: $9 → $10
Current: $0.0004
Upside: n/a
Jun 18, 2019
Reiterated: Buy
Price Target: $19 → $36
Current: $2.04
Upside: n/a
Aug 16, 2018
Reiterated: Buy
Price Target: $95
Current: $662.15
Upside: n/a
Apr 23, 2018
Reiterated: Hold
Price Target: $55 → $13
Current: $8.56
Upside: n/a
Dec 21, 2017
Initiated Coverage: Buy
Price Target: $19
Current: $9.79
Upside: n/a
Nov 28, 2017
Initiated Coverage: Buy
Price Target: $20
Current: $1.08
Upside: n/a
Oct 12, 2017
Reiterated: Buy
Price Target: $24 → $16
Current: $3.25
Upside: n/a
Oct 24, 2016
Reiterated: Hold
Price Target: $10 → $13
Current: $3.73
Upside: n/a
Aug 10, 2016
Reiterated: Hold
Price Target: $1.5 → $1
Current: $0.000001
Upside: n/a
Aug 3, 2016
Reiterated: Hold
Price Target: $2
Current: $1.15
Upside: n/a
May 9, 2016
Reiterated: Hold
Price Target: $4 → $3
Current: $28.16
Upside: n/a
Nov 17, 2015
Reiterated: Buy
Price Target: $16 → $9
Current: $0.7249
Upside: n/a
Mar 31, 2014
Reiterated: Sell
Price Target: n/a
Current: $98.97
Upside: n/a
Mar 22, 2013
Reiterated: Hold
Price Target: n/a
Current: $25.46
Upside: n/a